Related Experiment Video
Updated: May 30, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
Vladimíra Vojtová1, Milan Kolár, Kristýna Hricová
1Department of Pharmacology, Faculty of Medicine, Palacky University and University Hospital Olomouc, Czech Republic.
Abstract:
Pseudomonas aeruginosa is one of the most frequent and dangerous pathogens involved in the etiology of severe nosocomial infections. A retrospective observational study was conducted at all intensive care units of the University Hospital in Olomouc, Czech Republic (155 ICU beds). Complete antibiotic utilization data of the ICUs in the period of 1999 to 2008 were processed according to ATC/DDD system and expressed in defined daily doses per 100 bed-days (DBD). Utilization of meropenem, imipenem, ciprofloxacin, ofloxacin, pefloxacin, gentamicin, amikacin, ceftazidime, cefoperazone, cefoperazone/sulbactam and piperacillin/tazobactam was measured. Pseudomonas aeruginosa strains were isolated from clinical material obtained from patients hospitalized in ICUs. During the ten-year period, utilization of the entire group of antibiotics monitored grew. It increased from 23.52 DBD in 1999 to 27.48 DBD in 2008 with a peak of 33.04 DBD in 2007. P. aeruginosa accounted for as much as 42% of pneumonias and 23% of surgical wound infections. Our results show that P. aeruginosa strains became gradually resistant to all antibiotics used in the treatment of the infections caused by them, with the exception of amikacin and piperacillin/tazobactam.
Insights
Antibiotic use increased in intensive care units over ten years. Pseudomonas aeruginosa developed resistance to most treatments, except amikacin and piperacillin/tazobactam.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Hospital Epidemiology
Background:
- Pseudomonas aeruginosa is a significant cause of severe hospital-acquired infections.
- Nosocomial infections pose a major threat in intensive care units (ICUs).
Purpose of the Study:
- To analyze antibiotic utilization trends in ICUs.
- To investigate the antimicrobial resistance patterns of Pseudomonas aeruginosa in relation to antibiotic use.
Main Methods:
- Retrospective observational study of antibiotic utilization (ATC/DDD system) from 1999-2008 in a university hospital ICU.
- Monitoring of specific antibiotic classes including carbapenems, fluoroquinolones, aminoglycosides, and beta-lactams.
- Isolation and susceptibility testing of Pseudomonas aeruginosa strains from clinical samples.
Main Results:
- Overall antibiotic utilization increased from 23.52 to 27.48 defined daily doses per 100 bed-days between 1999 and 2008.
- Pseudomonas aeruginosa was a major pathogen, causing 42% of pneumonias and 23% of surgical wound infections.
- P. aeruginosa strains showed increasing resistance to most tested antibiotics, with amikacin and piperacillin/tazobactam remaining effective.
Conclusions:
- Rising antibiotic consumption in ICUs correlates with increasing antimicrobial resistance in Pseudomonas aeruginosa.
- Amikacin and piperacillin/tazobactam demonstrated sustained efficacy against P. aeruginosa during the study period.
- Effective antibiotic stewardship is crucial to combat nosocomial infections caused by resistant pathogens.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Development of Antibiotic Resistance